Related Experiment Video

Updated: Mar 29, 2026

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

14.6K

Targeting chemokine receptors for HIV: past, present and future

Simon P Fricker1

  • 1Biopharma, 13 Glenwood Lane, North Grafton, MA 01536, USA.

Future Medicinal Chemistry
|December 3, 2015
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CCR5CXCR4HIVchemokine receptormaravirocplerixafor

More Related Videos

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

20.0K
Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.8K

Related Experiment Videos

Last Updated: Mar 29, 2026

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

14.6K
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

20.0K
Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.8K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.6K

Articles linked to this work by shared authors, journal, and citation graph.

Self-delivering RNAi immunotherapeutic PH-762 silences PD-1 to generate local and abscopal antitumor efficacy.

Frontiers in immunology·2024

Characterization and Validation of Antibodies for Immunohistochemical Staining of the Chemokine CXCL12.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society·2018

Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue: ROLE OF ILE198.

The Journal of biological chemistry·2015

Chemokine receptor modeling: an interdisciplinary approach to drug design.

Future medicinal chemistry·2013

Physiology and pharmacology of plerixafor.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2013

The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor.

Biochemical pharmacology·2011

Latest developments of spirooxindoles and their derivatives in medicinal chemistry.

Future medicinal chemistry·2026

In silico and in vitro evaluation of new sulfonamide derivatives as VEGFR-2 inhibitors for cancer therapy.

Future medicinal chemistry·2026

Synthesis of novel thiazole derivatives linked benzonitrile moiety as potent antimicrobial agents.

Future medicinal chemistry·2026

Chalcone-indole hybrid scaffolds as promising anticancer drug candidates: a mini-review.

Future medicinal chemistry·2026

Progress and challenges in the design and development of selective KRAS G12D-targeted drug discovery: inhibitors, degraders and emerging therapeutic strategies.

Future medicinal chemistry·2026

Design, synthesis, and biological evaluation of imidazole-triazole hybrids as dual antimicrobial and antioxidant agents: experimental and in silico studies.

Future medicinal chemistry·2026

De Novo Molecular Design and Bioactivity Prediction of Novel Hexahydroquinolines as Plasmodium falciparum Calcium-Dependent Protein Kinase 4 (CDPK4) Inhibitors.

Bioinformatics and biology insights·2026

RNA Capping, Replication Complex Assembly, and Translational Regulation in Chikungunya Virus: Molecular Mechanisms and Antiviral Opportunities.

Cureus·2026

Corrigendum to "Metabolomic profiling of Musanga cecropioides leaf extract reveals cytotoxic mechanisms in MCF-7 breast cancer cells" [Pharm. Sci. Adv. 4 (2026) 100107].

Pharmaceutical science advances·2026

Discovery of antimicrobial naphtho-pyrone dimers and xanthone dimer derivatives from mangrove endophytic fungus Curvularia sp. via bioassay-guided isolation and HSQC-based DeepSAT analysis.

Marine life science & technology·2026

Structure-activity relationships and antibacterial membrane disruption of monoterpenoid ketones and lactones.

Food microbiology·2026

Molecular networking-assisted dereplication reveals Callistenone Q, a potent antileishmanial phloroglucinol from Melaleuca viminalis.

Fitoterapia·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us